Eton Pharmaceuticals (ETON) Gross Profit (2019 - 2025)
Eton Pharmaceuticals' Gross Profit history spans 7 years, with the latest figure at $13.1 million for Q4 2025.
- On a quarterly basis, Gross Profit rose 102.29% to $13.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.7 million, a 82.56% increase, with the full-year FY2025 number at $42.7 million, up 82.56% from a year prior.
- Gross Profit hit $13.1 million in Q4 2025 for Eton Pharmaceuticals, up from $7.9 million in the prior quarter.
- Over the last five years, Gross Profit for ETON hit a ceiling of $13.1 million in Q4 2025 and a floor of $121000.0 in Q3 2021.
- Historically, Gross Profit has averaged $6.0 million across 5 years, with a median of $5.7 million in 2021.
- Biggest five-year swings in Gross Profit: soared 343666.67% in 2021 and later crashed 87.13% in 2022.
- Tracing ETON's Gross Profit over 5 years: stood at $5.7 million in 2021, then rose by 11.17% to $6.4 million in 2022, then tumbled by 42.92% to $3.6 million in 2023, then surged by 78.4% to $6.5 million in 2024, then skyrocketed by 102.29% to $13.1 million in 2025.
- Business Quant data shows Gross Profit for ETON at $13.1 million in Q4 2025, $7.9 million in Q3 2025, and $11.9 million in Q2 2025.